EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Release of Mast Cell Mediators from Cochlear Tissue Following Short Exposure to Compound 48/80 or Cisplatin, and Their Damage to Cochlear Structure

Bin Zeng, Stefan Frischbutter iD, Sherezade Moñino-Romero iD, Jörg Scheffel iD, Frank Siebenhaar iD, Heidi Olze iD, Agnieszka J Szczepek iD

Cells · 17.10.2025 · 14 (20) · 1615

DOI: 10.3390/cells14201615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 17.10.2025. Verfasst von Bin Zeng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humbol…. Hauptthemen laut MEDLINE: Cisplatin, Mast Cells, Cochlea, p-Methoxy-N-methylphenethylamine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Scholarship Council, Open Access Publication Fund of Charité—Universitätsmedizin Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cochlea is susceptible to damage from ototoxic agents such as cisplatin, yet the mechanisms underlying cochlear injury remain incompletely understood. Mast cells (MCs), key immune players in allergic and inflammatory responses, have recently been identified in the rodent cochlea and implicated in cisplatin-induced ototoxicity. Our study investigated the role of MC degranulation in cochlear damage and evaluated the activation capacity of cochlear-resident MCs. Bone marrow-derived MCs (BMMCs) were cultured and induced to degranulate via IgE-anti-DNP/DNP stimulation, and the supernatants were applied to cochlear explants. Cochlear explants were also treated with Compound 48/80 (CP48/80) or cisplatin to assess MC activation. Morphological changes were assessed and hair cells (HC) quantified via phalloidin staining, while ELISA measured mediator release. Supernatants from degranulated BMMC induced a dose-dependent HC loss and tissue damage. A significant chymase and tryptase release was triggered by CP48/80 from cochlear MCs, with chymase elevation detected even at low concentrations. Cochlear MCs were rapidly activated by cisplatin exposure, elevating chymase and histamine levels, and the effects were attenuated by the MC stabilizer sodium cromolyn. Notably, tryptase remained undetectable post-cisplatin treatment, suggesting tissue-specific MC responses. These findings establish MC degranulation as an early event in cisplatin-induced cochlear injury, mediated by chymase and histamine. Our study highlights MCs as potential therapeutic targets for mitigating ototoxicity and underscores the need to explore MC-driven pathways in hearing loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinMast CellsCochleap-Methoxy-N-methylphenethylamineAnimalsCell DegranulationMiceHair Cells, AuditoryRats

Stichwörter der Autor:innen

cisplatincochleamast cellsmediatorsmouseototoxicity

Substanzen

Cisplatinp-Methoxy-N-methylphenethylamine

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 10117 Berlin, Germany.
  • Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, 12200 Berlin, Germany.
  • Faculty of Medicine and Health Sciences, University of Zielona Góra, 65-046 Zielona Góra, Poland.

ORCID-Profile: Stefan Frischbutter, Sherezade Moñino-Romero, Jörg Scheffel, Frank Siebenhaar, Heidi Olze, Agnieszka J Szczepek

Förderung

  • Chinese Scholarship Council
  • Open Access Publication Fund of Charité—Universitätsmedizin Berlin

Zitieren

APA

Zeng, B., Frischbutter, S., Moñino-Romero, S., Scheffel, J., Siebenhaar, F., Olze, H., & Szczepek, A. J. (2025). Release of Mast Cell Mediators from Cochlear Tissue Following Short Exposure to Compound 48/80 or Cisplatin, and Their Damage to Cochlear Structure. Cells, 14(20), 1615. https://doi.org/10.3390/cells14201615

Vancouver

Zeng B, Frischbutter S, Moñino-Romero S, Scheffel J, Siebenhaar F, Olze H, et al. Release of Mast Cell Mediators from Cochlear Tissue Following Short Exposure to Compound 48/80 or Cisplatin, and Their Damage to Cochlear Structure. Cells. 2025;14(20):1615. doi:10.3390/cells14201615

BibTeX
@article{Zeng2025,
  author = {Zeng, Bin and Frischbutter, Stefan and Moñino-Romero, Sherezade and Scheffel, Jörg and Siebenhaar, Frank and Olze, Heidi and Szczepek, Agnieszka J},
  title = {Release of Mast Cell Mediators from Cochlear Tissue Following Short Exposure to Compound 48/80 or Cisplatin, and Their Damage to Cochlear Structure},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {20},
  pages = {1615},
  doi = {10.3390/cells14201615}
}
Kostenlos starten →